These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29701141)

  • 21. Inhibitors of Trypanosoma brucei trypanothione reductase: comparative molecular field analysis modeling and structural basis for selective inhibition.
    Ferreira LG; Andricopulo AD
    Future Med Chem; 2013 Oct; 5(15):1753-62. PubMed ID: 24144411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-guided design of novel Trypanosoma brucei Methionyl-tRNA synthetase inhibitors.
    Huang W; Zhang Z; Barros-Álvarez X; Koh CY; Ranade RM; Gillespie JR; Creason SA; Shibata S; Verlinde CLMJ; Hol WGJ; Buckner FS; Fan E
    Eur J Med Chem; 2016 Nov; 124():1081-1092. PubMed ID: 27788467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A target-based high throughput screen yields Trypanosoma brucei hexokinase small molecule inhibitors with antiparasitic activity.
    Sharlow ER; Lyda TA; Dodson HC; Mustata G; Morris MT; Leimgruber SS; Lee KH; Kashiwada Y; Close D; Lazo JS; Morris JC
    PLoS Negl Trop Dis; 2010 Apr; 4(4):e659. PubMed ID: 20405000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of novel inhibitors of UDP-Glc 4'-epimerase, a validated drug target for african sleeping sickness.
    Urbaniak MD; Tabudravu JN; Msaki A; Matera KM; Brenk R; Jaspars M; Ferguson MA
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5744-7. PubMed ID: 16962325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the
    Shamshad H; Hafiz A; Althagafi II; Saeed M; Mirza AZ
    Curr Comput Aided Drug Des; 2020; 16(5):583-598. PubMed ID: 31453790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure and function of L-threonine-3-dehydrogenase from the parasitic protozoan Trypanosoma brucei revealed by X-ray crystallography and geometric simulations.
    Adjogatse E; Erskine P; Wells SA; Kelly JM; Wilden JD; Chan AWE; Selwood D; Coker A; Wood S; Cooper JB
    Acta Crystallogr D Struct Biol; 2018 Sep; 74(Pt 9):861-876. PubMed ID: 30198897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding to large enzyme pockets: small-molecule inhibitors of trypanothione reductase.
    Persch E; Bryson S; Todoroff NK; Eberle C; Thelemann J; Dirdjaja N; Kaiser M; Weber M; Derbani H; Brun R; Schneider G; Pai EF; Krauth-Siegel RL; Diederich F
    ChemMedChem; 2014 Aug; 9(8):1880-91. PubMed ID: 24788386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
    Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
    Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-based design of pteridine reductase inhibitors targeting African sleeping sickness and the leishmaniases.
    Tulloch LB; Martini VP; Iulek J; Huggan JK; Lee JH; Gibson CL; Smith TK; Suckling CJ; Hunter WN
    J Med Chem; 2010 Jan; 53(1):221-9. PubMed ID: 19916554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting a Large Active Site: Structure-Based Design of Nanomolar Inhibitors of Trypanosoma brucei Trypanothione Reductase.
    De Gasparo R; Halgas O; Harangozo D; Kaiser M; Pai EF; Krauth-Siegel RL; Diederich F
    Chemistry; 2019 Sep; 25(49):11416-11421. PubMed ID: 31407832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery and antiparasitic activity of AZ960 as a Trypanosoma brucei ERK8 inhibitor.
    Valenciano AL; Ramsey AC; Santos WL; Mackey ZB
    Bioorg Med Chem; 2016 Oct; 24(19):4647-4651. PubMed ID: 27519462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic validation of aldolase and glyceraldehyde-3-phosphate dehydrogenase as drug targets in Trypanosoma brucei.
    Cáceres AJ; Michels PA; Hannaert V
    Mol Biochem Parasitol; 2010 Jan; 169(1):50-4. PubMed ID: 19748525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel naphthalene-based inhibitors of Trypanosoma brucei RNA editing ligase 1.
    Durrant JD; Hall L; Swift RV; Landon M; Schnaufer A; Amaro RE
    PLoS Negl Trop Dis; 2010 Aug; 4(8):e803. PubMed ID: 20808768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis, and structure-activity relationship of Trypanosoma brucei leucyl-tRNA synthetase inhibitors as antitrypanosomal agents.
    Ding D; Meng Q; Gao G; Zhao Y; Wang Q; Nare B; Jacobs R; Rock F; Alley MR; Plattner JJ; Chen G; Li D; Zhou H
    J Med Chem; 2011 Mar; 54(5):1276-87. PubMed ID: 21322634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of the glycolytic enzymes in the trypanosome: an approach in the development of new leads in the therapy of parasitic diseases.
    Perie J; Riviere-Alric I; Blonski C; Gefflaut T; Lauth de Viguerie N; Trinquier M; Willson M; Opperdoes FR; Callens M
    Pharmacol Ther; 1993 Nov; 60(2):347-65. PubMed ID: 8022865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cruzain inhibitors: efforts made, current leads and a structural outlook of new hits.
    Martinez-Mayorga K; Byler KG; Ramirez-Hernandez AI; Terrazas-Alvares DE
    Drug Discov Today; 2015 Jul; 20(7):890-8. PubMed ID: 25697479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and biological evaluation of potent azadipeptide nitrile inhibitors and activity-based probes as promising anti-Trypanosoma brucei agents.
    Yang PY; Wang M; Li L; Wu H; He CY; Yao SQ
    Chemistry; 2012 May; 18(21):6528-41. PubMed ID: 22488888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective tight binding inhibitors of trypanosomal glyceraldehyde-3-phosphate dehydrogenase via structure-based drug design.
    Aronov AM; Verlinde CL; Hol WG; Gelb MH
    J Med Chem; 1998 Nov; 41(24):4790-9. PubMed ID: 9822549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the HSP60/10 chaperonin systems of Trypanosoma brucei as a strategy for treating African sleeping sickness.
    Abdeen S; Salim N; Mammadova N; Summers CM; Goldsmith-Pestana K; McMahon-Pratt D; Schultz PG; Horwich AL; Chapman E; Johnson SM
    Bioorg Med Chem Lett; 2016 Nov; 26(21):5247-5253. PubMed ID: 27720295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacophore identification of ascofuranone, potent inhibitor of cyanide-insensitive alternative oxidase of Trypanosoma brucei.
    Saimoto H; Kido Y; Haga Y; Sakamoto K; Kita K
    J Biochem; 2013 Mar; 153(3):267-73. PubMed ID: 23180806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.